With over twenty years of experience in oncology, liquid biopsy, and molecular diagnostics, Dr. Wang will bring his expertise in clinical research, product development, and management to BioFluidica in 2022. As Vice President of Translational Medicine at BioFluidica, he drives and manages disease initiatives and clinical applications. Before joining BioFluidica, Dr. Wang served as the Vice President of Informatics at Mindera Health, Senior Director of Translational Research at Epic Sciences, and Director of Bioinformatics at AltheaDx, where he led the development of multiple clinical tests, genomics analysis pipelines, and machine learning algorithms. Mr. Wang has over 60 peerreviewed publications in journals, including sciences, PNAS, Blood and Cancer Research, etc. He earned an M.D. and Ph.D. from Jilin University and a certificate in business management.